 - Regimen 1 acute leukemia, myelodysplastic syndromes, myeloproliferative syndrome, or chronic myelogenous leukemia: Patients receive fludarabine phosphate IV over 30 minutes and busulfan IV over 3 hours on days -6 to -3 or orally 4 times daily on days -7 to -3. 